Jade Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,514	956	1,511	628	724	288
Market Cap Growth	535.64%	-36.76%	140.56%	-13.27%	151.70%	-
Enterprise Value	1,054	620.28	1,550	506.51	596.25	121
Last Close Price	23.81	15.43	92.75	792.05	1025.50	412.65
PB Ratio	3.44	2.87	-32.29	5.74	5.72	1.67
P/TBV Ratio	2.87	1.46	-	5.44	5.66	0.84
Debt / Equity Ratio	0.00	0.00	-2.30	0.00	0.01	0.00
Net Debt / Equity Ratio	-1.05	-1.01	-0.82	-1.11	-1.01	-0.97
Net Debt / EBITDA Ratio	2.80	2.96	-0.51	1.50	2.41	7.25
Net Debt / FCF Ratio	3.73	3.54	-0.54	2.14	3.26	6.05
Quick Ratio	14.61	20.33	5.78	6.94	16.61	65.64
Current Ratio	14.93	21.09	5.81	7.04	16.90	68.37
Return on Equity (ROE)	-39.68%	-89.18%	-222.24%	-63.95%	-34.44%	-26.19%
Return on Assets (ROA)	-40.06%	-53.71%	-74.57%	-62.02%	-34.29%	-25.57%
Return on Invested Capital (ROIC)	-	-392.11%	-307.89%	-	-2518.34%	-1155.58%
Return on Capital Employed (ROCE)	-42.58%	-57.63%	-87.46%	-68.61%	-35.45%	-26.20%
Buyback Yield / Dilution	-	-3740.15%	-8.55%	-7.60%	-99.06%	-
Total Shareholder Return	-	-3740.15%	-8.55%	-7.60%	-99.06%	-

SEC Filings: 10-K · 10-Q